Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00682695 · ClinicalTrials.gov registry record

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

A clinical trial of Stroke, sponsored by State University of New York at Buffalo.

Recruiting
Registry status
1,000
Enrollment target
7
Study locations

NCT00682695 is a study of Stroke that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 1,000 participants, below the 12,014-participant average among 454 other Stroke trials with a reported enrollment target (92% lower). The trial reports 7 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00682695, a study of Stroke, is actively recruiting participants, sponsored by State University of New York at Buffalo.

RECRUITING
Registry status
1,000 participants
Enrollment target
7
Study locations

Study Summary

The purpose of this study is to find risk factors for hemorrhagic stroke.

Conditions Studied

Study Locations (7)

Illinois

  • University of Illinois Chicago - Chicago

Kentucky

  • Baptist Health Louisville - Louisville

Maryland

  • University of Maryland - Baltimore

Massachusetts

  • Massachusetts General Hospital - Boston

New York

  • Columbia University - New York

North Carolina

  • Duke University - Durham

Ohio

  • University of Cincinnati - Cincinnati

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2025-01-01
Est. Completion 2029-12-31

What the Registry Record Tells You About NCT00682695

The ClinicalTrials.gov registry entry for NCT00682695 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,014-participant average among 454 other Stroke trials with a reported enrollment target (92% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 0 interventions.

NCT00682695 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Illinois, Kentucky, Maryland.

Frequently Asked Questions

What is clinical trial NCT00682695 about?

NCT00682695 is a clinical study titled "Genetic and Environmental Risk Factors for Hemorrhagic Stroke". The purpose of this study is to find risk factors for hemorrhagic stroke.

What is the current status of trial NCT00682695?

This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-01-01. Estimated completion is 2029-12-31.

What conditions does trial NCT00682695 study?

This clinical trial studies the following conditions: Stroke.

Who is sponsoring clinical trial NCT00682695?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00682695 being conducted?

This trial has 7 study locations across Illinois, Kentucky, Maryland, Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.